PLAU and gastric adenocarcinoma: In this study uPA and uPAR were assessed on intestinal-type gastric adenocarcinomas and could not be associated with prognosis or recurrence-free survival; however, PAI-1 overexpression was an independent factor for recurrence-free survival [91].